CUSIP: 654405109
Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
28,567,492
-
Share change
-
+28,564,692
-
Total reported value
-
$16,223,781
-
Price per share
-
$0.57
-
Number of holders
-
22
-
Value change
-
+$16,222,781
-
Number of buys
-
21
Quarterly Holders Quick Answers
What is CUSIP 654405109?
CUSIP 654405109 identifies NMTR - 9 METERS BIOPHARMA INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 654405109:
Institutional Holders of 9 METERS BIOPHARMA INC - COM (NMTR) as of Q2 2020
As of 30 Jun 2020,
9 METERS BIOPHARMA INC - COM (NMTR) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,567,492 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Granite Point Capital Management, L.P., VANGUARD GROUP INC, BlackRock Inc., Tower Research Capital LLC (TRC), GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, Qube Research & Technologies Ltd, NORTHERN TRUST CORP, and Summit X, LLC.
This page lists
22
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.